The likeliest cause is not dieting or exercise but pharmaceuticals, specifically GLP-1 drugs
1 GLP-1 slows down gastric emptying (how fast food moves from your stomach to your intestines) and regulates blood sugar levels
They suppress appetite, slow gastric emptying and help users feel fuller longer on significantly fewer calories
It is also unclear whether generic entry will be subject to any restrictions imposed by Novo Nordisk, such as volume limited distribution over a period of time
The effect was nominally significant for the GIPR/GLP-1R agonist (Beta: 0.35, 95%CI: 0.010.69, P = 0.046), while the associations for the GCGR/GLP-1R agonist (Beta: 0.28, 95%CI: 0.070.49, P = 7.97 10 3 ) and the GCGR/GIPR/GLP-1R agonist (Beta: 0.39, 95%CI: 0.110.66, P = 5.67 10 3 ) remained significant after multiple testing (Fig
M.ProotP.ChiangY